Close Call Among Three Bariatric Strategies
The newest innovation in bariatric surgery -- sleeve gastrectomy -- landed between gastric bypass and adjustable banding for safety and efficacy in a review of more than 250,000 bariatric procedures.
For the primary efficacy outcome of 30-day mortality, patients treated by sleeve gastrectomy had a rate of 0.08 percent, almost exactly halfway between gastric banding at 0.03 percent and gastric bypass at 0.14 percent. An identical order emerged for serious complications, reoperation, and readmission.
The same was true for median 12-month body mass index (BMI), which was 34.1 with sleeve gastrectomy versus 31.2 for gastric bypass and 37.5 for gastric banding, John Morton, MD, reported here at the American Society for Metabolic and Bariatric Surgery meeting.